AAAAAA

   
Results: 1-20 |
Results: 20
HER-2 NEU ONCOGENIC PROTEIN - ISSUES IN VACCINE DEVELOPMENT/
Authors: DISIS ML CHEEVER MA
Citation: Ml. Disis et Ma. Cheever, HER-2 NEU ONCOGENIC PROTEIN - ISSUES IN VACCINE DEVELOPMENT/, Critical reviews in immunology, 18(1-2), 1998, pp. 37-45
PEPTIDE-BASED VACCINES FOR IMMUNIZATION TO HER-2 NEU, AN ONCOGENIC SELF PROTEIN/
Authors: CHEEVER MA DISIS ML
Citation: Ma. Cheever et Ml. Disis, PEPTIDE-BASED VACCINES FOR IMMUNIZATION TO HER-2 NEU, AN ONCOGENIC SELF PROTEIN/, Pathologie et biologie, 46(2), 1998, pp. 126-126
HUMAN HER-2 NEU PROTEIN IMMUNIZATION CIRCUMVENTS TOLERANCE TO RAT NEU- A VACCINE STRATEGY FOR SELF TUMOR-ANTIGENS/
Authors: DISIS ML SHIOTA FM CHEEVER MA
Citation: Ml. Disis et al., HUMAN HER-2 NEU PROTEIN IMMUNIZATION CIRCUMVENTS TOLERANCE TO RAT NEU- A VACCINE STRATEGY FOR SELF TUMOR-ANTIGENS/, Immunology, 93(2), 1998, pp. 192-199
GENETIC IMMUNIZATION OF PATIENTS WITH METASTATIC BREAST-CANCER USING A CD80 (B7.1)-MODIFIED, HLA-A2+, HER2 NEU+, ALLOGENEIC BREAST-CANCER CELL VACCINE PLUS GM-CSF/
Authors: SMITH JW SCHOOF DD DISIS ML BRANTZAWADSKI P WOOD W DORAN T JOHNSON E URBA WJ
Citation: Jw. Smith et al., GENETIC IMMUNIZATION OF PATIENTS WITH METASTATIC BREAST-CANCER USING A CD80 (B7.1)-MODIFIED, HLA-A2+, HER2 NEU+, ALLOGENEIC BREAST-CANCER CELL VACCINE PLUS GM-CSF/, Cancer gene therapy, 4(6), 1997, pp. 122-122
HIGH-TITER HER-2 NEU PROTEIN-SPECIFIC ANTIBODY CAN BE DETECTED IN PATIENTS WITH EARLY-STAGE BREAST-CANCER/
Authors: DISIS ML PUPA SM GRALOW JR DITTADI R MENARD S CHEEVER MA
Citation: Ml. Disis et al., HIGH-TITER HER-2 NEU PROTEIN-SPECIFIC ANTIBODY CAN BE DETECTED IN PATIENTS WITH EARLY-STAGE BREAST-CANCER/, Journal of clinical oncology, 15(11), 1997, pp. 3363-3367
IDENTIFICATION OF HER-2 NEU CTL EPITOPES USING DOUBLE TRANSGENIC MICEEXPRESSING HLA-A2.1 AND HUMAN CD.8/
Authors: LUSTGARTEN J THEOBALD M LABADIE C LAFACE D PETERSON P DISIS ML CHEEVER MA SHERMAN LA
Citation: J. Lustgarten et al., IDENTIFICATION OF HER-2 NEU CTL EPITOPES USING DOUBLE TRANSGENIC MICEEXPRESSING HLA-A2.1 AND HUMAN CD.8/, Human immunology, 52(2), 1997, pp. 109-118
ONCOGENIC PROTEINS AS TUMOR-ANTIGENS
Authors: DISIS ML CHEEVER MA
Citation: Ml. Disis et Ma. Cheever, ONCOGENIC PROTEINS AS TUMOR-ANTIGENS, Current opinion in immunology, 8(5), 1996, pp. 637-642
DENDRITIC CELLS LOSE ABILITY TO PRESENT PROTEIN ANTIGEN AFTER STIMULATING ANTIGEN-SPECIFIC T-CELL RESPONSES, DESPITE UP-REGULATION OF MHC CLASS-II EXPRESSION
Authors: HAND SL BERNHARD H HUSEBY ES GRALOW JR DISIS ML BATTEN WY OHLEN C CHEEVER MA
Citation: Sl. Hand et al., DENDRITIC CELLS LOSE ABILITY TO PRESENT PROTEIN ANTIGEN AFTER STIMULATING ANTIGEN-SPECIFIC T-CELL RESPONSES, DESPITE UP-REGULATION OF MHC CLASS-II EXPRESSION, The FASEB journal, 10(6), 1996, pp. 1234-1234
IMMUNIZATION WITH HOMOLOGOUS FOREIGN PROTEINS GENERATES IMMUNITY AGAINST SELF TUMOR-ANTIGENS
Authors: DISIS ML SHIOTA FM MURPHYMOULTON G SMITH J CHEEVER MA
Citation: Ml. Disis et al., IMMUNIZATION WITH HOMOLOGOUS FOREIGN PROTEINS GENERATES IMMUNITY AGAINST SELF TUMOR-ANTIGENS, The FASEB journal, 10(6), 1996, pp. 2709-2709
PEPTIDE-BASED, BUT NOT WHOLE PROTEIN, VACCINES ELICIT IMMUNITY TO HER-2 NEU, AN ONCOGENIC SELF-PROTEIN/
Authors: DISIS ML GRALOW JR BERNHARD H HAND SL RUBIN WD CHEEVER MA
Citation: Ml. Disis et al., PEPTIDE-BASED, BUT NOT WHOLE PROTEIN, VACCINES ELICIT IMMUNITY TO HER-2 NEU, AN ONCOGENIC SELF-PROTEIN/, The Journal of immunology, 156(9), 1996, pp. 3151-3158
GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - AN EFFECTIVE ADJUVANT FOR PROTEIN AND PEPTIDE-BASED VACCINES
Authors: DISIS ML BERNHARD H SHIOTA FM HAND SL GRALOW JR HUSEBY ES GILLIS S CHEEVER MA
Citation: Ml. Disis et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR - AN EFFECTIVE ADJUVANT FOR PROTEIN AND PEPTIDE-BASED VACCINES, Blood, 88(1), 1996, pp. 202-210
ANTIBODY TO RAS PROTEINS IN PATIENTS WITH COLON-CANCER
Authors: TAKAHASHI M CHEN W BYRD DR DISIS ML HUSEBY ES QIN HL MCCAHILL L NELSON H SHIMADA H OKUNO K YASUTOMI M PEACE DJ CHEEVER MA
Citation: M. Takahashi et al., ANTIBODY TO RAS PROTEINS IN PATIENTS WITH COLON-CANCER, Clinical cancer research, 1(10), 1995, pp. 1071-1077
GENERATION OF IMMUNOSTIMULATORY DENDRITIC CELLS FROM HUMAN CD34-MARROW AND PERIPHERAL-BLOOD( HEMATOPOIETIC PROGENITOR CELLS OF THE BONE)
Authors: BERNHARD H DISIS ML HUSEBY ES HAND S GRALOW JR RISDON G HEIMFELD S CHEEVER MA
Citation: H. Bernhard et al., GENERATION OF IMMUNOSTIMULATORY DENDRITIC CELLS FROM HUMAN CD34-MARROW AND PERIPHERAL-BLOOD( HEMATOPOIETIC PROGENITOR CELLS OF THE BONE), Journal of cellular biochemistry, 1995, pp. 24-24
IMMUNITY TO ONCOGENIC PROTEINS
Authors: CHEEVER MA DISIS ML BERNHARD H GRALOW JR HAND SL HUSEBY ES QIN HL TAKAHASHI M CHEN W
Citation: Ma. Cheever et al., IMMUNITY TO ONCOGENIC PROTEINS, Immunological reviews, 145, 1995, pp. 33-59
GENERATION OF IMMUNOSTIMULATORY DENDRITIC CELLS FROM HUMAN CD34-MARROW AND PERIPHERAL-BLOOD( HEMATOPOIETIC PROGENITOR CELLS OF THE BONE)
Authors: BERNHARD H DISIS ML HEIMFELD S HAND S GRALOW JR CHEEVER MA
Citation: H. Bernhard et al., GENERATION OF IMMUNOSTIMULATORY DENDRITIC CELLS FROM HUMAN CD34-MARROW AND PERIPHERAL-BLOOD( HEMATOPOIETIC PROGENITOR CELLS OF THE BONE), Cancer research, 55(5), 1995, pp. 1099-1104
CD4(-CELL IMMUNITY TO MUTATED RAS PROTEIN IN PANCREATIC AND COLON-CANCER PATIENTS() T)
Authors: QIN HL CHEN W TAKAHASHI M DISIS ML BYRD DR MCCAHILL L BERTRAM KA FENTON RG PEACE DJ CHEEVER MA
Citation: Hl. Qin et al., CD4(-CELL IMMUNITY TO MUTATED RAS PROTEIN IN PANCREATIC AND COLON-CANCER PATIENTS() T), Cancer research, 55(14), 1995, pp. 2984-2987
HUMAN BONE-MARROW-DERIVED DENDRITIC CELLS PRIME NAIVE T-LYMPHOCYTES TO FOREIGN AND SELF-ANTIGENS IMPLICATION FOR VACCINE STRATEGIES
Authors: BERNHARD H HUSEBY ES DISIS ML HAND SL GRALOW JR OHLEN C BATTEN WY RISDON G HEIMFELD S ZUMBUSCHENFELDE KHM CHEEVER MA
Citation: H. Bernhard et al., HUMAN BONE-MARROW-DERIVED DENDRITIC CELLS PRIME NAIVE T-LYMPHOCYTES TO FOREIGN AND SELF-ANTIGENS IMPLICATION FOR VACCINE STRATEGIES, Blood, 86(10), 1995, pp. 1697-1697
IN-VITRO GENERATION OF HUMAN CYTOLYTIC T-CELLS SPECIFIC FOR PEPTIDES DERIVED FROM THE HER-2 NEU PROTOONCOGENE PROTEIN/
Authors: DISIS ML SMITH JW MURPHY AE CHEN W CHEEVER MA
Citation: Ml. Disis et al., IN-VITRO GENERATION OF HUMAN CYTOLYTIC T-CELLS SPECIFIC FOR PEPTIDES DERIVED FROM THE HER-2 NEU PROTOONCOGENE PROTEIN/, Cancer research, 54(4), 1994, pp. 1071-1076
EXISTENT T-CELL AND ANTIBODY IMMUNITY TO HER-2 NEU PROTEIN IN PATIENTS WITH BREAST-CANCER
Authors: DISIS ML CALENOFF E MCLAUGHLIN G MURPHY AE CHEN W GRONER B JESCHKE M LYDON N MCGLYNN E LIVINGSTON RB MOE R CHEEVER MA
Citation: Ml. Disis et al., EXISTENT T-CELL AND ANTIBODY IMMUNITY TO HER-2 NEU PROTEIN IN PATIENTS WITH BREAST-CANCER, Cancer research, 54(1), 1994, pp. 16-20
INDUCTION OF T-CELLS SPECIFIC FOR THE MUTATED SEGMENT OF ONCOGENIC P21(RAS) PROTEIN BY IMMUNIZATION IN-VIVO WITH THE ONCOGENIC PROTEIN
Authors: PEACE DJ SMITH JW DISIS ML CHEN W CHEEVER MA
Citation: Dj. Peace et al., INDUCTION OF T-CELLS SPECIFIC FOR THE MUTATED SEGMENT OF ONCOGENIC P21(RAS) PROTEIN BY IMMUNIZATION IN-VIVO WITH THE ONCOGENIC PROTEIN, Journal of immunotherapy with emphasis on tumor immunology, 14(2), 1993, pp. 110-114
Risultati: 1-20 |